Institute of Protein Biochemistry, Ulm University, Helmholtzstraße 8/1, 89081, Ulm, Germany.
Max Planck Research Unit for Enzymology of Protein Folding, Weinbergweg 22, 06120, Halle (Saale), Germany.
Sci Rep. 2017 Jul 21;7(1):6170. doi: 10.1038/s41598-017-06419-1.
Amyloid A (AA) amyloidosis is a systemic protein misfolding disease affecting humans and other vertebrates. While the protein precursor in humans and mice is the acute-phase reactant serum amyloid A (SAA) 1.1, the deposited fibrils consist mainly of C-terminally truncated SAA fragments, termed AA proteins. For yet unknown reasons, phenotypic variations in the AA amyloid distribution pattern are clearly associated with specific AA proteins. Here we describe a bacterial expression system and chromatographic strategies to obtain significant amounts of C-terminally truncated fragments of murine SAA1.1 that correspond in truncation position to relevant pathological AA proteins found in humans. This enables us to investigate systematically structural features of derived fibrils. All fragments form fibrils under nearly physiological conditions that show similar morphological appearance and amyloid-like properties as evident from amyloid-specific dye binding, transmission electron microscopy and infrared spectroscopy. However, infrared spectroscopy suggests variations in the structural organization of the amyloid fibrils that might be derived from a modulating role of the C-terminus for the fibril structure. These results provide insights, which can help to get a better understanding of the molecular mechanisms underlying the different clinical phenotypes of AA amyloidosis.
淀粉样 A (AA) 淀粉样变性是一种影响人类和其他脊椎动物的系统性蛋白质错误折叠疾病。虽然人类和小鼠中的蛋白质前体是急性期反应物血清淀粉样蛋白 A (SAA) 1.1,但沉积的纤维主要由 C 末端截断的 SAA 片段组成,称为 AA 蛋白。由于未知原因,AA 淀粉样蛋白分布模式的表型变异显然与特定的 AA 蛋白有关。在这里,我们描述了一种细菌表达系统和色谱策略,以获得大量与人相关的病理性 AA 蛋白相对应的 C 末端截断的小鼠 SAA1.1 片段。这使我们能够系统地研究衍生纤维的结构特征。所有片段在几乎生理条件下形成纤维,从淀粉样蛋白特异性染料结合、透射电子显微镜和红外光谱可以明显看出,这些纤维具有相似的形态外观和淀粉样特性。然而,红外光谱表明,淀粉样纤维的结构组织存在差异,这可能源于 C 末端对纤维结构的调节作用。这些结果提供了一些见解,可以帮助更好地理解 AA 淀粉样变性不同临床表型的分子机制。